NAMS
NewAmsterdam Pharma Company N.V.NASDAQStock$30.35+1.01 (+3.46%)Mkt Cap 3.5BP/E —Div Yield —Beta 0.03Vol 1.8MAvg Vol 1.3M
52W$17.96
$41.45
ETFs That Hold NAMS (NewAmsterdam Pharma Company N.V.)
1M
-19.84%
3M
+1.58%
6M
-14.40%
YTD
-14.03%
1Y
+43.89%
3Y
+148.03%
5Y
+208.46%
ETFs That Hold NAMS
NewAmsterdam Pharma Company N.V. is held by 21 ETFs. The largest position by market value is in CGMM (Capital Group U.S. Small and Mid Cap ETF).
| ETF | Fund Name | Weight |
|---|---|---|
| EAOK | iShares ESG Aware 30/70 Conservative Allocation ETF | 0.00% |
Excludes leveraged and inverse ETFs.
PreviousPage 2 of 2
Frequently Asked Questions
How many ETFs hold NAMS?
NewAmsterdam Pharma Company N.V. (NAMS) is held by 21 ETFs (excluding leveraged and inverse funds). The largest position by market value is in CGMM (Capital Group U.S. Small and Mid Cap ETF).
What is the largest ETF that holds NAMS?
By fund size, CGMM (Capital Group U.S. Small and Mid Cap ETF) with $2.87B in AUM holds 0.70% of its portfolio in NAMS, representing $20.3M in market value.
What percentage of SBIO is NAMS?
NAMS makes up 2.49% of SBIO (ALPS Medical Breakthroughs ETF), making it one of the largest positions in that fund.
Is NAMS in the S&P 500?
NAMS is not currently a component of the S&P 500 index based on available ETF holdings data.
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.